Literature DB >> 21815060

Preparation, maintenance, and use of serum-free aggregating brain cell cultures.

Paul Honegger1, Antoinette Defaux, Florianne Monnet-Tschudi, Marie-Gabrielle Zurich.   

Abstract

Serum-free aggregating brain cell cultures are free-floating three-dimensional primary cell cultures able to reconstitute spontaneously a histotypic brain architecture to reproduce critical steps of brain development and to reach a high level of structural and functional maturity. This culture system offers, therefore, a unique model for neurotoxicity testing both during the development and at advanced cellular differentiation, and the high number of aggregates available combined with the excellent reproducibility of the cultures facilitates routine test procedures. This chapter presents a detailed description of the preparation, maintenance, and use of these cultures for neurotoxicity studies and a comparison of the developmental characteristics between cultures derived from the telencephalon and cultures derived from the whole brain. For culture preparation, mechanically dissociated embryonic brain tissue is used. The initial cell suspension, composed of neural stem cells, neural progenitor cells, immature postmitotic neurons, glioblasts, and microglial cells, is kept in a serum-free, chemically defined medium under continuous gyratory agitation. Spherical aggregates form spontaneously and are maintained in suspension culture for several weeks. Within the aggregates, the cells rearrange and mature, reproducing critical morphogenic events, such as migration, proliferation, differentiation, synaptogenesis, and myelination. For experimentation, replicate cultures are prepared by the randomization of aggregates from several original flasks. The high yield and reproducibility of the cultures enable multiparametric endpoint analyses, including "omics" approaches.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21815060     DOI: 10.1007/978-1-61779-170-3_6

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  4 in total

1.  In vitro models to study insulin and glucocorticoids modulation of trimethyltin (TMT)-induced neuroinflammation and neurodegeneration, and in vivo validation in db/db mice.

Authors:  Jenny Sandström; Denise V Kratschmar; Alex Odermatt; Florianne Monnet-Tschudi; Alexandra Broyer; Olivier Poirot; Philippe Marbet; Boonrat Chantong; Fanny Zufferey; Tania Dos Santos; Julien Boccard; Roman Chrast
Journal:  Arch Toxicol       Date:  2019-04-16       Impact factor: 5.153

Review 2.  State-of-the-art of 3D cultures (organs-on-a-chip) in safety testing and pathophysiology.

Authors:  Natalie Alépée; Anthony Bahinski; Mardas Daneshian; Bart De Wever; Ellen Fritsche; Alan Goldberg; Jan Hansmann; Thomas Hartung; John Haycock; Helena Hogberg; Lisa Hoelting; Jens M Kelm; Suzanne Kadereit; Emily McVey; Robert Landsiedel; Marcel Leist; Marc Lübberstedt; Fozia Noor; Christian Pellevoisin; Dirk Petersohn; Uwe Pfannenbecker; Kerstin Reisinger; Tzutzuy Ramirez; Barbara Rothen-Rutishauser; Monika Schäfer-Korting; Katrin Zeilinger; Marie-Gabriele Zurich
Journal:  ALTEX       Date:  2014-07-14       Impact factor: 6.043

3.  International STakeholder NETwork (ISTNET): creating a developmental neurotoxicity (DNT) testing road map for regulatory purposes.

Authors:  Anna Bal-Price; Kevin M Crofton; Marcel Leist; Sandra Allen; Michael Arand; Timo Buetler; Nathalie Delrue; Rex E FitzGerald; Thomas Hartung; Tuula Heinonen; Helena Hogberg; Susanne Hougaard Bennekou; Walter Lichtensteiger; Daniela Oggier; Martin Paparella; Marta Axelstad; Aldert Piersma; Eva Rached; Benoît Schilter; Gabriele Schmuck; Luc Stoppini; Enrico Tongiorgi; Manuela Tiramani; Florianne Monnet-Tschudi; Martin F Wilks; Timo Ylikomi; Ellen Fritsche
Journal:  Arch Toxicol       Date:  2015-01-25       Impact factor: 5.153

4.  Stochastic time-concentration activity models for cytotoxicity in 3D brain cell cultures.

Authors:  Maria Renner; Marie-Gabrielle Zurich; Annette Kopp-Schneider
Journal:  Theor Biol Med Model       Date:  2013-03-14       Impact factor: 2.432

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.